Literature DB >> 15608679

Myb proteins regulate the expression of diverse target genes.

Georgina Lang1, Jonathan R White, Mary J G Argent-Katwala, Christopher G Allinson, Kathleen Weston.   

Abstract

Hematopoiesis, the process by which mature blood cells arise, is controlled by multiple transcription factors, which act in stage- and lineage-specific complexes. It is a major goal to elucidate the genes regulated by these transcription factors, in order to obtain a full understanding of the process and its malignant counterpart, leukemia. Myb family transcription factors play a central role in hematopoiesis. To identify new Myb family target genes, we have used an inducible dominant-negative protein for a subtraction cloning protocol in a model cell system (FDCP-Mix) with many characteristics of normal hematopoiesis. We present here a novel group of 29 validated Myb family target genes of diverse functions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15608679     DOI: 10.1038/sj.onc.1208301

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  23 in total

1.  Regulation of hematopoietic stem cells by their mature progeny.

Authors:  Carolyn A de Graaf; Maria Kauppi; Tracey Baldwin; Craig D Hyland; Donald Metcalf; Tracy A Willson; Marina R Carpinelli; Gordon K Smyth; Warren S Alexander; Douglas J Hilton
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-29       Impact factor: 11.205

2.  Consistent deregulation of gene expression between human and murine MLL rearrangement leukemias.

Authors:  Zejuan Li; Roger T Luo; Shuangli Mi; Miao Sun; Ping Chen; Jingyue Bao; Mary Beth Neilly; Nimanthi Jayathilaka; Deborah S Johnson; Lili Wang; Catherine Lavau; Yanming Zhang; Charles Tseng; Xiuqing Zhang; Jian Wang; Jun Yu; Huanming Yang; San Ming Wang; Janet D Rowley; Jianjun Chen; Michael J Thirman
Journal:  Cancer Res       Date:  2009-01-20       Impact factor: 12.701

3.  c-Myb contributes to G2/M cell cycle transition in human hematopoietic cells by direct regulation of cyclin B1 expression.

Authors:  Yuji Nakata; Susan Shetzline; Chizuko Sakashita; Anna Kalota; Ravikumar Rallapalli; Stephen I Rudnick; Yi Zhang; Stephen G Emerson; Alan M Gewirtz
Journal:  Mol Cell Biol       Date:  2007-01-22       Impact factor: 4.272

4.  c-Myb promotes the survival of CD4+CD8+ double-positive thymocytes through upregulation of Bcl-xL.

Authors:  Joan Yuan; Rowena B Crittenden; Timothy P Bender
Journal:  J Immunol       Date:  2010-02-08       Impact factor: 5.422

5.  MiR-148a promotes apoptosis by targeting Bcl-2 in colorectal cancer.

Authors:  H Zhang; Y Li; Q Huang; X Ren; H Hu; H Sheng; M Lai
Journal:  Cell Death Differ       Date:  2011-04-01       Impact factor: 15.828

6.  Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: Incidence, variability, and clinicopathologic significance.

Authors:  Yoshitsugu Mitani; Jie Li; Pulivarthi H Rao; Yi-Jue Zhao; Diana Bell; Scott M Lippman; Randal S Weber; Carlos Caulin; Adel K El-Naggar
Journal:  Clin Cancer Res       Date:  2010-08-11       Impact factor: 12.531

7.  Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck.

Authors:  Marta Persson; Ywonne Andrén; Joachim Mark; Hugo M Horlings; Fredrik Persson; Göran Stenman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-19       Impact factor: 11.205

8.  Myb-induced chromatin remodeling at a dual enhancer/promoter element involves non-coding rna transcription and is disrupted by oncogenic mutations of v-myb.

Authors:  Carola Wilczek; Olesya Chayka; Annette Plachetka; Karl-Heinz Klempnauer
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

9.  c-Maf increases apoptosis in peripheral CD8 cells by transactivating Caspase 6.

Authors:  Siying Peng; Hailong Wu; Yin-Yuan Mo; Kounosuke Watabe; Mary E Pauza
Journal:  Immunology       Date:  2009-06       Impact factor: 7.397

10.  Myb proteins regulate expression of histone variant H2A.Z during thymocyte development.

Authors:  Joel Hooper; Diane Maurice; Mary J G Argent-Katwala; Kathleen Weston
Journal:  Immunology       Date:  2007-10-11       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.